All
Fortifeye launches Eye Pressure and Neuro Cognitive Support supplement
March 4th 2024The supplement is specifically crafted to promote healthy intraocular pressure (IOP), nurturing the well-being of retinal ganglion cells, and sustain the health of the retinal nerve fiber layer while boosting memory and concentration.
PulseSight Therapeutics launches to advance non-viral gene therapies for severe retinal diseases
March 1st 2024According to the company, its proprietary non-viral gene therapy platform with minimally invasive delivery technology is providing long lasting gene expression and favorable distribution in the retina.
Treatment developed to dramatically slow progression of blindness-causing retinal disease
February 22nd 2024Researchers have found that the interactive release of anti-inflammatory drugs depend on the level of retinal degeneration. A customized treatment approach is expected to be developed to reduce patients’ inconvenience of having multiple shots.
EnVision Summit 2024: Using the miCOR 700 device for phacoemulsification cataract surgery
February 21st 2024Anthony Mai, MD, shared results from using the miCOR 700 device, which is a new device from Zeiss, for phacoemulsification cataract surgery at the EnVision Summit 2024. He spoke with Peg Achenbach, OD, FAAO, Executive Director/Global Ambassador Strategies, Ophthalmology and Optometry at MJH Life sciences, on location in Puerto Rico to share more about his presentation.